Vaginal progesterone in risk reduction of preterm birth in women with short cervix in the midtrimester of pregnancy

@inproceedings{Khandelwal2012VaginalPI,
  title={Vaginal progesterone in risk reduction of preterm birth in women with short cervix in the midtrimester of pregnancy},
  author={Meena Khandelwal},
  booktitle={International journal of women's health},
  year={2012}
}
Preterm birth is a major health problem for the neonate, family, country, and society in general. Despite many risk factors being identified for women destined to deliver preterm, short cervical length detected on transvaginal ultrasound is the most plausible, practical and sensitive risk factor for prediction of spontaneous preterm birth. The definition of short cervix has varied in various studies, but most commonly accepted is ≤2.5 cm in the midtrimester of pregnancy, though risk of… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 79 references

490: Two year infant outcomes for children exposed to supplemental intravaginal progesterone gel in utero: secondary analysis of a multicenter, randomized, double-blind, placebo-controlled trial

  • JM O’Brien, JJ Steichen, JA Phillips, GW. Creasy
  • Am J Obstet Gynecol
  • 2012
2 Excerpts

National Institute of Health and Human Development. Randomized controlled trial of progesterone treatment for preterm birth prevention in nulliparous women with cervical length less than 30 mm

  • WA Grobman, for the Eunice Kennedy Shriver
  • Am J Obstet Gynecol
  • 2012

Randomized controlled trial of progesterone treatment for preterm birth prevention in nulliparous women with cervical length less than 30 mm

  • WA Grobman
  • Am J Obstet Gynecol
  • 2012

Similar Papers

Loading similar papers…